Source link : https://newshealth.biz/health-news/wins-for-cabozantinib-in-kidney-cancer-brain-mets-aggressive-disease-subtype/
(MedPage Today) — DENVER — A majority of patients with non-locally treated brain metastases from kidney cancer remained free of metastatic progression for at least 6 months when treated with cabozantinib (Cabometyx), a small prospective study… Source link : https://www.medpagetoday.com/meetingcoverage/ikcs/118548 Author : Publish date : 2025-11-15 22:44:00 Copyright for syndicated content belongs to the linked […]
The post Wins for Cabozantinib in Kidney Cancer Brain Mets, Aggressive Disease Subtype first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-15 22:44:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8